Vyome Holdings Licenses Selective JAK Inhibitors from Impetis Biosciences
Key Highlights: Implications: Vyome is buying its way into a...
Key Highlights: Implications: Vyome is buying its way into a...
Key Highlights: Implications: The expanded BAT2506 deal...